ORIGINAL RESEARCH article

Front. Immunol.

Sec. Cytokines and Soluble Mediators in Immunity

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1608101

This article is part of the Research TopicComputational Strategies in Analyzing Cell Signaling Networks: Applications and InnovationsView all articles

An assembled molecular signaling map of Interleukin-24 (IL-24): A resource to decipher its multifunctional immunoregulatory role in pathophysiological conditions

Provisionally accepted
Anjana  AravindAnjana Aravind1Vineetha  ShajiVineetha Shaji1Dr. Mukhtar  AhmedDr. Mukhtar Ahmed2Shobha  DagamajaluShobha Dagamajalu1Manavalan  VijayakumarManavalan Vijayakumar3*T. S. Keshava  PrasadT. S. Keshava Prasad1*Rajesh  RajuRajesh Raju1*
  • 1Yenepoya University, Mangalore, Karnataka, India
  • 2King Saud University, Riyadh, Riyadh, Saudi Arabia
  • 3Yenepoya Medical College, Mangalore, Karnataka, India

The final, formatted version of the article will be published soon.

Interleukin-24 (IL-24) is a cytokine belonging to the IL-10 family with immunoregulatory properties. It is known to induce cellular responses in various disease conditions, including inflammatory, infectious diseases, and cancer, in a receptor-dependent and independent manner. IL-24 is induced by both immune and non-immune cells and acts on a vast array of target cells to regulate various biological processes. The antitumor and immunoregulatory properties of IL-24 support its application as a therapeutic agent in a vast array of pathological conditions.Characterizing the molecular events associated with its immunomodulatory properties is essential for evaluating its utility in cancer immunotherapy.The data related to signaling events induced by IL-24 were then manually annotated and cataloged from the literature related pertaining to IL-24 signaling. The cataloged molecular events were then manually drawn based on the topology as a signaling pathway map of IL-24.Based on the data mined from published literature, we assembled IL-24-regulated signaling events linked to its immunoregulatory and anti-tumor activities. The receptor-ligand interaction of IL-24 regulates multiple downstream signaling cascades, leading to antitumor activities alongside inducing inflammatory reactions and anti-infectious processes. We provide a signaling pathway map of IL-24 consisting of 433 mRNAs/proteins and their 613 signaling events.We believe this map would serve as a knowledge base for reference and one-go visualization of the signaling events identified to be induced by IL-24. Moreover, this map is made available (https://ciods.in/il24/) for the researchers to explore the role of IL-24 in various pathophysiological conditions through the gene set enrichment of transcriptomics or proteomics datasets from various disease conditions.

Keywords: Tumor suppressor cytokine, immune cells, Therapeutic agent, Immuno-stimulation, signaling pathway

Received: 11 Apr 2025; Accepted: 10 Jun 2025.

Copyright: © 2025 Aravind, Shaji, Ahmed, Dagamajalu, Vijayakumar, Prasad and Raju. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Manavalan Vijayakumar, Yenepoya Medical College, Mangalore, 575018, Karnataka, India
T. S. Keshava Prasad, Yenepoya University, Mangalore, 575018, Karnataka, India
Rajesh Raju, Yenepoya University, Mangalore, 575018, Karnataka, India

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.